摘要
Xenotransplantation,involving animal organ transplantation into humans to address the human organ shortage,has been studied since the 17th century.Early attempts to obtain organs from animals such as goats,dogs,and non-human primates proved unsuccessful.In the 1990s,scientists agreed that pigs were the most suitable donor animals for xenotransplantation.However,immune rejection between pig and human has hindered the application.To overcome these challenges,researchers developed genetically modified pigs that deactivate xenoreactive antigen genes and express human protective genes.These advances extended xenograft survival from days to years in non-human primates,resulting in the first human heart xenotransplant trial.Using genetically engineered pigs for the organ shortage is promising.This review provides an overview of potential incompatibilities of immunogenicity and functional proteins related to xenotransplantation between humans and pigs.Furthermore,it elucidates possible approaches for multiplex gene modification to breed better-humanized pigs for clinical xenotransplantation.
基金
supported by the National Key Research and Development Program of China(2022YFA1105404,2021YFF0702601 and 2021YFA0805300)
the Research Unit of Generation of Large Animal Disease Models,Chinese Academy of Medical Sciences(2019I2M-5-025)
the Science and Technology Program of Guangzhou(202201010409)
the Key Research&Development Program of Hainan Province(ZDYF2021SHFZ052)
the Major Science and Technology Project of Hainan Province(ZDKJ2021030)
the 2020 Research Program of Sanya Yazhou Bay Science and Technology City(202002011)
作者简介
Han Wu,Contributed equally to this work;Meng Lian,Contributed equally to this work;Corresponding author:Liangxue Lai,email:lai_liangxue@gibh.ac.cn
